Aleksandra Jankovic | Genetics and Molecular Biology | Research Excellence Award

Aleksandra Jankovic | Genetics and Molecular Biology | Research Excellence Award

Institute for Biological Research “Siniša Stanković” – National Institute of Republic of Serbia, University of Belgrade | Serbia

Dr. Aleksandra Janković is a Scientific Advisor at the Institute for Biological Research “Siniša Stanković” – National Institute of the Republic of Serbia, University of Belgrade. She completed her BSc in Biology in 2004 and earned a PhD in Animal and Human Physiology in 2010 from the University of Belgrade. Her research focuses on redox biology, metabolism, and mitochondrial physiology, contributing significantly to understanding cellular and physiological processes. Over the course of her career, she has progressed through multiple research positions at the Institute for Biological Research, including Research Trainee, Research Assistant, Research Associate, and Senior Research Associate, before attaining her current role. She has an established scientific record with over 1,300 citations (excluding self-citations) and an h-index of 22, reflecting her impactful contributions to the field.

Citation Metrics (Scopus) – Aleksandra Jankovic

15001200

900

600

300

0

Citations1,499
Documents70
h-index22

Citations

Documents

h-index

View Scopus Profile
View google Scholar Profile
View Orcid Profile

Featured Publications


Tissue-specific changes in antioxidant defence during ageing: the effect of chronic cold exposure

– Journal of Comparative Physiology B, 2026 [cite: 20, 22]

Nrf2-driven redox coupling of tumour and associated adipose tissue during early tumour growth in an orthotopic breast cancer model

– Free Radical Biology and Medicine, 2025 [cite: 28]

Mitochondrial uncoupling proteins: redox-metabolic homeostasis and disease pathogenesis

– Review Article [cite: 28]

Metabolic remodeling of visceral and subcutaneous white adipose tissue during reacclimation of rats after cold

– Applied Physiology Nutrition and Metabolism, 2024 [cite: 28]

Breast Cancer: Mitochondria-Centered Metabolic Alterations in Tumor and Associated Adipose Tissue

– Cells, 2024 [cite: 28]

Georgia Braliou | Genetics and Molecular Biology | Research Excellence Award

Georgia Braliou | Genetics and Molecular Biology | Research Excellence Award

University of Thessaly | Greece

Dr Braliou is a scientist specializing in Molecular Biology, Biochemistry, and Genetic Epidemiology. She obtained her academic training in Chemistry and later completed her PhD in Molecular Biology and Biochemistry through research conducted at leading European institutions, including the European Molecular Biology Laboratory and Radboud University Nijmegen. Her research primarily focuses on gene regulation mechanisms, including transcriptional control by nuclear receptors, cis-regulatory DNA elements, and epigenetic modifications. She has also contributed to understanding the regulation of hepcidin by hypoxia-induced factors during her postdoctoral work at the University of Thessaly. Expanding into computational biology and bioinformatics, her work integrates genetic epidemiology approaches, particularly in analyzing SNPs, gene expression, and GWAS data using statistical and computational methods.

Citation Metrics (Scopus)

800

600

400

200

0

Citations
637

Documents
28

h-index
12


View Scopus Profile
View Google Scholar Profile
View Orcid Profile
View Scilit Profile
View SciProfiles Profile

Featured Publications

Featured Publications


Antibody tests in detecting SARS-COV-2 infection: a meta-analysis
Diagnostics

– 2020 — Cited by 334

Transport of hypoxia-inducible factor HIF-1α into the nucleus involves importins 4 and 7
Biochemical and Biophysical Research Communications

– 2009 — Cited by 127

2-Oxoglutarate-dependent oxygenases control hepcidin gene expression

– Journal of Hepatology, 2008 — Cited by 98

Antioxidant Activity of Leaf Extracts from Stevia rebaudiana Bertoni: A Systematic Review and Meta-Analysis

–Nutrients, 2023 — Cited by 505

Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo

– The EMBO Journal, 1998 — Cited by 41

Shuang Guo | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Shuang Guo | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Dr Shuang Guo, Tsinghua University Affiliated Beijing Tsinghua Changgung Hospital: Beijing Tsinghua Changgung Hospital, China

Dr. Shuang Guo is a dedicated postdoctoral researcher at Beijing Tsinghua Changgung Hospital, affiliated with the School of Clinical Medicine at Tsinghua University. With a Ph.D. in Clinical Medicine from the prestigious Huazhong University of Science and Technology, Dr. Guo has contributed significantly to the field of cardiovascular and genetic diseases. Her multidisciplinary research approach bridges clinical practice with cutting-edge molecular science, emphasizing hereditary arrhythmias, hypertension, and vascular disorders. Dr. Guo has published influential articles in international journals and is actively involved in innovation, holding several patents related to vascular health and gastrointestinal treatments. As a passionate investigator and co-developer of novel diagnostic and therapeutic strategies, she consistently pushes the boundaries of translational medicine. Dr. Guo’s dedication to scientific excellence and patient-centered research continues to enhance understanding and treatment of complex hereditary and vascular diseases in China and beyond.

Publication Profile

orcid

Education 

Dr. Shuang Guo earned her Ph.D. in Clinical Medicine from the Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, one of China’s top institutions in medical education and biomedical research. During her doctoral training, she cultivated a solid foundation in cardiovascular pathology, molecular diagnostics, and translational medicine. Her academic journey was marked by hands-on clinical exposure combined with deep exploration of hereditary diseases, enabling her to integrate lab-based discoveries with bedside care. The program offered her robust mentorship and multidisciplinary collaboration opportunities that enhanced her clinical insight and research acumen. This rigorous educational experience provided the basis for her continued research excellence and led directly to her postdoctoral appointment at Tsinghua University. Her academic background also includes comprehensive training in medical genetics, vascular physiology, and clinical trial design, which continues to inform her postdoctoral investigations into novel treatments and personalized care for cardiovascular and hereditary disorders.

Experience

Currently serving as a postdoctoral researcher at Beijing Tsinghua Changgung Hospital, affiliated with the School of Clinical Medicine, Tsinghua University, Dr. Shuang Guo focuses on vascular biology, hereditary cardiovascular diseases, and precision medicine. Her postdoctoral work includes conducting high-impact research, co-authoring clinical trials, and filing patents on molecular therapies for gastrointestinal and vascular diseases. She collaborates with a multidisciplinary team of clinicians, biologists, and bioengineers to translate laboratory findings into therapeutic solutions. Before her postdoc, she gained extensive research experience at Huazhong University of Science and Technology, where she contributed to translational cardiovascular studies and clinical case analyses at Union Hospital. Dr. Guo is also actively engaged in manuscript writing, grant applications, and patent development, underscoring her commitment to innovation and collaboration. Her professional journey demonstrates a strong intersection of research excellence and clinical relevance, with a focus on improving diagnostic and therapeutic outcomes in genetically mediated and vascular-related conditions.

Awards and Honors

While specific named awards are not listed, Dr. Shuang Guo’s contributions to the medical and scientific community are demonstrated through her leadership as first author in multiple peer-reviewed journals, co-first authorship in a major JACC publication, and her involvement in five innovative patents related to gastrointestinal and vascular health. Her research has garnered recognition in respected publications such as Genes, Journal of Vascular Surgery, and JACC: Basic to Translational Science, reflecting high scholarly merit. These achievements speak to her excellence in both foundational research and applied clinical studies. Dr. Guo’s role in inventing novel uses of inulin, identifying mutation genes associated with hypercholesterolemia, and contributing to the development of therapeutic applications for short-chain fatty acids highlights her contribution to innovation. Her growing reputation in cardiovascular and hereditary disease research underscores her role as a rising scientific leader. Future recognition is likely as her contributions continue to impact global healthcare.

Research Focus

Dr. Shuang Guo’s research is rooted in clinical and molecular investigation of hereditary cardiovascular and gastrointestinal diseases. Her primary focus areas include genetic arrhythmias, monogenic hypertension, vascular inflammation, and abdominal aortic aneurysms. She is particularly interested in translational research—bridging the gap between genetic findings and clinical applications. Her work explores the therapeutic potential of dietary fibers like inulin and microbiota-derived short-chain fatty acids in modulating immune responses and vascular health. Dr. Guo’s ongoing studies involve identifying novel genetic mutations linked to hypercholesterolemia and other inherited conditions. She applies molecular biology, clinical diagnostics, and bioinformatics to uncover mechanisms underlying disease progression. Her research also emphasizes the role of immune modulation in disease treatment, especially via regulatory T-cell activity in vascular disorders. Through multidisciplinary collaboration, she aims to develop minimally invasive strategies and precision-based therapies to improve patient care, focusing on personalized medicine in complex, genetically-influenced disease models.

Publication Top Notes

  • 📘 Pathogenesis and Clinical Characteristics of Hereditary Arrhythmia DiseasesGenes, 2024.

  • 📗 Selective Minimally Invasive Strategy for Acute Superior Mesenteric Artery ObstructionJournal of Vascular Surgery, 2025.

  • 📙 Propionate Alleviates Abdominal Aortic Aneurysm by Modulating Colonic Regulatory T-Cell Expansion and RecirculationJACC: Basic to Translational Science, 2022.

  • 📕 Research Advances in Monogenic Inherited Hypertension中国医学前沿杂志(电子版), 2024